Anticoagulation therapy in patients with heart failure due to systolic dysfunction and sinus rhythm: Analysis of REDINSCOR registry;Tratamiento anticoagulante en pacientes con insuficiencia cardiaca por disfunción sistólica y ritmo sinusal: análisis del registro REDINSCOR

Revista Espanola de Cardiologia

Volumn 65, Issue 8, 2012, Pages 705-712

  Avellana, Patricia ^a   Segovia, Javier ^a   Ferrero, Andreu ^b   Vázquez, Rafael ^c   Brugada, Josep ^d   Borrás, Xavier ^b   Alonso Pulpón, Luis ^a   Cinca, Juan ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Anticoagulation; Systolic heart failure; Thromboembolic events

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; MORTALITY; MULTICENTER STUDY; QRS COMPLEX; SCORING SYSTEM; SINUS RHYTHM; SYSTOLIC DYSFUNCTION;

AGED; ANTICOAGULANTS; ARRHYTHMIA, SINUS; COHORT STUDIES; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTRIES; SPAIN; STROKE VOLUME;

EID: 84864130570     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.11.012     Document Type: Article

References (25)

1. M. Jessup, W. Abraham, D. Casey, A. Feldman, G. Francis, and T. Ganiats 2009 Focused update incorporated into the ACC/AHA 2005 guidelines of the diagnosis and management of heart failure in adults Circulation 119 2009 1977 2016
2. G.Y. Lip, and C.R. Gibbs Does heart failure confer a hypercoagulable state? Virchow's triad revisited J Am Coll Cardiol 33 1999 1424 1426
3. K. Dickstein, A. Cohen-Solal, G. Filippatos, J. Mc Murray, P. Ponikowski, and P. Poole-Wilson ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 Eur Heart J 29 2008 2388 2442
4. A.S. Al-Khadra, D.N. Salem, W.M. Rand, E. Udelson, J. Smith, and M.A. Konstam Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction J Am Coll Cardiol 31 1998 749 753
5. W.B. Dunkman, G.R. Johnson, P.E. Carson, G. Bhat, L. Farrell, and J.N. Cohn Incidence of thromboembolic events in congestive heart failure Circulation 87 1993 VI94 VI101
6. E. Loh, M. St John Sutton, C.C. Wun, J.L. Rouleau, G.C. Flaker, and S.S. Gottlieb Ventricular dysfunction and the risk of stroke after myocardial infarction N Engl J Med 336 1997 251 257
7. J.G. Cleland, I. Findlay, S. Jafri, G. Sutton, R. Falk, and C. Bulpitt The Warfarin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure Am Heart J 148 2004 157 164
8. B.M. Massie, J.F. Collins, S.E. Ammon, P.W. Armstrong, J.G. Cleland, and M. Ezekowitz Randomization trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial Circulation 119 2009 1616 1624
9. D.V. Cokkinos, G.C. Haralabopoulos, J.B. Kostis, P.K. Toutouzas HELAS investigators Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study Eur J Heart Fail 8 2006 428 432
10. 2-VASc scores Eur J Neurol 19 2012 473 479 doi:10.1111/j.1468-1331.2011.03547.x. Epub 2011 Oct 4
11. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, and W. Hacke Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
12. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
13. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, and M. Hanna Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
14. S. Snowden, and L. Silus Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction Cardiol Rev 19 2011 36 40
15. L. Alonso Pulpón, X. Borrás, J. Brugada, J. Cinca, A. Fernández Cruz, J. González Juanatey Red de Investigación clínica y básica en insuficiencia cardiaca (REDINSCOR) Redes temáticas de investigación cooperativa del Instituto de Salud Carlos III Rev Esp Cardiol 61 2008 76 81
16. J. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva, and S. Ernst Guidelines for the management of atrial brillation Eur Heart J 31 2010 2369 2429
17. C. Pattanayak, D. Rubin, and E. Zell Métodos de puntuación de propensión para crear una distribución equilibrada de las covariables en los estudios observacionales Rev Esp Cardiol 64 2011 897 903
18. R.S. Freudenberger, A.S. Hellkamp, J.L. Halperin, J. Poole, J. Anderson, G. Jonson SCD-HeFT Investigators Risk of thromboembolism in heart failure: an analysis from the the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation 115 2007 2637 2641
19. M. Mujib, A. Rahman, R. Desai, M. Ahmed, M. Feller, and I. Aban Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves Am J Cardiol 107 2011 552 557
20. G.C. Griffith, R. Strangnell, D.C. Levinson, F.J. Moore, and A.G. Ware A study of the beneficial effects of anticoagulant therapy in congestive heart failure Ann Intern Med 37 1952 867 887
21. W.P. Harvey, and C.A. Finch Dicumarol prophylaxis of thromboembolic disease in congestive heart failure N Engl J Med 242 1950 208 211
22. J.G. Cleland, J. Ghosh, N. Freemantle, G.C. Kaye, M. Nasir, and A.L. Clark Clinical trials update and cumulative meta-analyses form the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronization therapy in heart failure Eur J Heart Fail 6 2004 501 508
23. P. Pullicino, J.L. Thompson, B. Barton, B. Levin, S. Graham, and R.S. Freudenberger Warfarin versus aspirin in patients with reduced cardiac ejection fraction: rationale, objectives, and design J Card Fail 12 2006 39 46
24. F.J. Van der Meer, F.R. Rosendaal, W. Vandenbroucke, and E. Briët Bleeding complications in oral anticoagulant therapy Arch Intern Med 153 1993 1557 1562
25. L. Bettari, M. Fiuzat, R. Becker, M. Felker, M. Metra, and C. OConnor Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions Circ Heart Fail 4 2011 361 368